● Adolor Corp (ADLR) ● - 500 Beiträge pro Seite

[kosto1929]

Sehr abhängig von einem Produkt (Entereg) - Was meint ihr zu Adolor?

Adolor Corporation is a biopharmaceutical corporation specializing in the discovery, development and commercialization of prescription pain management products. Entereg (alvimopan), its lead product candidate, is being developed to manage postoperative ileus (POI), a gastrointestinal (GI) side effect. Entereg is being evaluated as an oral dosage form for patients undergoing certain types of major abdominal surgery. It is also being developed to manage the opioid bowel dysfunction (OBD), which can negatively impact the quality of life of patients using opioid analgesic products, such as morphine, for treating pain. Entereg is also being evaluated as a treatment for chronic constipation. The Company`s next product candidate is a sterile lidocaine patch in clinical development for treating postoperative incisional pain. The Company also has a number of discovery research programs focused on the identification of novel compounds for the treatment of pain.

[Marktbetrachter]

Entereg (Alvimopan) hat den Fast Track Status von der FDA
bekommen und es könnte in den nächsten Wochen schon zur
Zulassung kommen.Kurse um 18-22 Dollar wären dann realistisch.



Stellt das Alvimopan für Adolor her und sollte davon auch profitieren.

Nur so am Rande


Gruß MB